ARCHIVES

Oxaliplatin Added To 5-FU/LV Improves Disease-Free Survival In Early Colon Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 6 | June 24, 2005

Download PDF Visit The Full Archive

Related Articles

HCFA Chief Says Facts Will Not Matter, She Won’t Loosen DRGs For Clinical Trials Unless Congress Orders It

May 4, 1984

FDA Approves Gleevec For First Line Rx Of CML

January 31, 2003

Clinical Trials Approved By NCI CTEP Last Month

January 28, 2011

M.D. Anderson, SWOG To Use Web-Based Software To Expand Access To Trials.

September 29, 2000

In Brief: Huntsman Cancer Institute Joins NCCN: Howard cancer Center To Honor Mandela

November 7, 1997

In Brief: Yates To leave NCI for Roswell Park: Isselbacher Heads MGH Center; Pinsky Moves Up At BRMP

June 12, 1987